Under-fire drug giant Valeant Pharmaceuticals International won’t put Bausch & Lomb on the block, investor Bill Ackman told CNBC.
Under-fire drug giant Valeant Pharmaceuticals International won’t put Bausch & Lomb on the block, investor Bill Ackman told CNBC.